{
    "clinical_study": {
        "@rank": "52020", 
        "arm_group": [
            {
                "arm_group_label": "HQ\u2122 Matrix Medical Wound Dressing", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Soho\u00ae Silk Wound Dressing", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the safety and effectiveness of HQ\u2122 Matrix Medical\n      Wound Dressing for the use as a dressing for healing of second degree burns and donor site\n      wounds."
        }, 
        "brief_title": "Evaluation of HQ\u2122 Matrix Medical Wound Dressing for Healing of Second Degree Burns and Donor Site Wounds", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Second Degree Burns", 
            "Donor Site Wounds"
        ], 
        "condition_browse": {
            "mesh_term": "Burns"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-60 years of age; of either gender and in good general health\n\n          -  Wounds resulting from second degree burns or donor site wounds\n\n          -  Wound size between 20-600 cm\u00b2\n\n          -  Participant agrees to participate in follow-up evaluation\n\n          -  Participant must be able to read and understand informed consent, and sign the\n             informed consent\n\n        Exclusion Criteria:\n\n          -  Concurrent participation in another clinical trial that involves an investigational\n             drug or device that would interfere with this study\n\n          -  Participant is to receive another topical antimicrobial agent other than the study\n             dressing\n\n          -  Participant with sensitivity or adverse reactions to silver or zinc\n\n          -  Pregnancy or nursing an infant or child\n\n          -  Immunosuppression\n\n          -  Active or systemic infection\n\n          -  Peripheral vascular occlusive disease\n\n          -  Decision impairment\n\n          -  Connective tissue disease\n\n          -  Participant undergoing active cancer chemotherapy\n\n          -  Chronic steroid use"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "204", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993030", 
            "org_study_id": "XY-201301"
        }, 
        "intervention": [
            {
                "arm_group_label": "HQ\u2122 Matrix Medical Wound Dressing", 
                "description": "Dressing indicated for second degree burns and donor site wounds. Dressing changes every 2-3 days, more frequently if needed", 
                "intervention_name": "HQ\u2122 Matrix Medical Wound Dressing", 
                "intervention_type": "Device", 
                "other_name": "HQ\u2122 Matrix"
            }, 
            {
                "arm_group_label": "Soho\u00ae Silk Wound Dressing", 
                "description": "Dressing indicated for second degree burns and donor site wounds. Dressing changes every 2-3 days, more frequently if needed", 
                "intervention_name": "Soho\u00ae Silk Wound Dressing", 
                "intervention_type": "Device", 
                "other_name": "Soho\u00ae"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Wound dressing", 
            "Second Degree Burns", 
            "Donor Site Wounds"
        ], 
        "lastchanged_date": "November 19, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Jianda Zhou, PhD", 
                    "phone": "+86-13508493668"
                }, 
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China", 
                        "state": "Hunan", 
                        "zip": "410013"
                    }, 
                    "name": "The Third Xiangya Hospital"
                }, 
                "investigator": {
                    "last_name": "Jianda Zhou, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Li Qian", 
                    "phone": "+86-0731-84896038"
                }, 
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China", 
                        "state": "Hunan", 
                        "zip": "410011"
                    }, 
                    "name": "The Second Xiangya Hospital"
                }, 
                "investigator": {
                    "last_name": "Li Qian", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "zhoujianda@hotmail.com", 
            "last_name": "Jianda Zhou, PhD", 
            "phone": "+86-13508493668"
        }, 
        "overall_official": {
            "affiliation": "The Third Xiangya Hospital", 
            "last_name": "Jianda Zhou, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Wound closure over time", 
            "safety_issue": "Yes", 
            "time_frame": "21 days post-operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993030"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Granulation tissue", 
                "safety_issue": "Yes", 
                "time_frame": "21days post-operation"
            }, 
            {
                "measure": "Wound infection", 
                "safety_issue": "Yes", 
                "time_frame": "21days post-operation"
            }, 
            {
                "description": "VAS scoring", 
                "measure": "Pain perceived by patient", 
                "safety_issue": "Yes", 
                "time_frame": "21days post-operation"
            }, 
            {
                "measure": "Exudation", 
                "safety_issue": "Yes", 
                "time_frame": "21days post-operation"
            }
        ], 
        "source": "Zhejiang Xingyue Biotechnology Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zhejiang Xingyue Biotechnology Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}